Trademark: 79379326
Word
ENDOPORE
Status
Pending
Status Code
661
Status Date
Tuesday, September 10, 2024
Serial Number
79379326
Mark Type
4
Filing Date
Tuesday, July 25, 2023

Trademark Owner History

Classifications
5 Pharmaceutical preparations for intracellular delivery of drugs; veterinary preparations for intracellular delivery of drugs; pharmaceutical preparations for gene editing; veterinary preparations for gene editing; pharmaceutical preparations for intracellular delivery of therapeutic substances focused on the development of RNA therapies; veterinary preparations for intracellular delivery of therapeutic substances focused on the development of RNA therapies; pharmaceutical preparations for intracellular delivery of therapeutic substances focused on non-viral delivery technology; veterinary preparations for intracellular delivery of therapeutic substances focused on non-viral delivery technology; pharmaceutical preparations for intracellular delivery of nucleic acids; veterinary preparations for intracellular delivery of nucleic acids; pharmaceutical preparations for intracellular delivery of proteins; veterinary preparations for intracellular delivery of proteins; pharmaceutical preparations for intracellular delivery of peptides; veterinary preparations for intracellular delivery of peptides; pharmaceutical preparations for intracellular delivery of small molecules; veterinary preparations for intracellular delivery of small molecules; pharmaceutical substances for intracellular delivery of drugs; pharmaceutical substances for gene editing; pharmaceutical substances for intracellular delivery of therapeutic substances focused on the development of RNA therapies; pharmaceutical substances for intracellular delivery of therapeutic substances focused on non-viral delivery technology; pharmaceutical substances for intracellular delivery of nucleic acids; pharmaceutical substances for intracellular delivery of proteins; pharmaceutical preparations for intracellular delivery peptides; pharmaceutical substances for intracellular delivery of peptides; pharmaceutical substances for intracellular delivery of small molecules; pharmaceutical compositions and preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer
35 Compilation of information into computer databases in the medical field
44 Medical services; medical analysis for the diagnosis and treatment of persons; pharmacy advice, namely, preparation of prescriptions in pharmacies and providing medical advice related to pharmaceutics; advisory services relating to health; advisory services relating to medical services; health care, namely, arranging of medical treatment; consultancy relating to health care; health advice and information services; health care; health care services; health centres being health clinic services; health clinic services; information services relating to health care; medical information retrieval services; health care, namely, medical treatment services; medical health assessment services; health care, namely, preparation of reports relating to health care matters; professional consultancy relating to health; providing health information; provision of health care services; provision of medical services; provision of medical information relating to medical practitioners; provision of medical information relating to medical specialists; services for the provision of medical care information; information, advisory and consultancy services relating to all of the aforesaid
42 Scientific and technological services, namely, scientific research, technological research, and research and design, all in the fields of intracellular delivery of drugs, gene editing, intracellular delivery of therapeutic substances focused on the development of RNA therapies, intracellular delivery of therapeutic substances focused on non-viral delivery technology, intracellular delivery of nucleic acids, intracellular delivery of proteins, intracellular delivery of peptides, and intracellular delivery of small molecules; research services in the fields of intracellular delivery of drugs, gene editing, intracellular delivery of therapeutic substances focused on the development of RNA therapies, intracellular delivery of therapeutic substances focused on non-viral delivery technology, intracellular delivery of nucleic acids, intracellular delivery of proteins, intracellular delivery of peptides, and intracellular delivery of small molecules; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; medical research laboratories; medical research laboratory services; medical research; medical research services; pharmaceutical drug development services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of vaccines and medicines; research of pharmaceuticals; research relating to medicines; research relating to pharmaceuticals; scientific investigations for medical purposes; scientific research and development; scientific research in the field of pharmacy; medical research, namely, services for assessing the efficacy of pharmaceuticals; information, advisory and consultancy services relating to all of the aforesaid

Trademark Events
Apr 17, 2024
Refusal Processed By Mpu
Sep 21, 2023
Sn Assigned For Sect 66a Appl From Ib
Sep 22, 2023
New Application Office Supplied Data Entered
Sep 26, 2023
Application Filing Receipt Mailed
Mar 27, 2024
Assigned To Examiner
Mar 30, 2024
Non-Final Action Written
Mar 31, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Apr 17, 2024
Non-Final Action Mailed - Refusal Sent To Ib
May 8, 2024
Refusal Processed By Ib
Jul 19, 2024
Limitation Of Goods Received From Ib
Sep 10, 2024
Correspondence Received In Law Office
Sep 10, 2024
Teas/Email Correspondence Entered
Sep 10, 2024
Teas Change Of Owner Address Received
Sep 10, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 10, 2024
Teas Response To Office Action Received
Aug 2, 2024
Limitation Of Goods Received From Ib
Sep 10, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 10, 2024
Teas Change Of Correspondence Received
Sep 10, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered

Trademark Alertz updated from USPTO on 2030-01-24